These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 18355957)

  • 1. Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.
    Zhang Y; Akinmade D; Hamburger AW
    Cancer Lett; 2008 Jul; 265(2):298-306. PubMed ID: 18355957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.
    Zhang Y; Linn D; Liu Z; Melamed J; Tavora F; Young CY; Burger AM; Hamburger AW
    Mol Cancer Ther; 2008 Oct; 7(10):3176-86. PubMed ID: 18852121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.
    Lu Y; Zhou H; Chen W; Zhang Y; Hamburger AW
    Breast Cancer Res Treat; 2011 Feb; 126(1):27-36. PubMed ID: 20379846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of the ErbB3 binding protein Ebp1 by protein kinase C.
    Lessor TJ; Hamburger AW
    Mol Cell Endocrinol; 2001 Apr; 175(1-2):185-91. PubMed ID: 11325528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.
    Akinmade D; Talukder AH; Zhang Y; Luo WM; Kumar R; Hamburger AW
    Br J Cancer; 2008 Mar; 98(6):1132-40. PubMed ID: 18283314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heregulin regulates the ability of the ErbB3-binding protein Ebp1 to bind E2F promoter elements and repress E2F-mediated transcription.
    Zhang Y; Hamburger AW
    J Biol Chem; 2004 Jun; 279(25):26126-33. PubMed ID: 15073182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ectopic expression of the ErbB-3 binding protein ebp1 inhibits growth and induces differentiation of human breast cancer cell lines.
    Lessor TJ; Yoo JY; Xia X; Woodford N; Hamburger AW
    J Cell Physiol; 2000 Jun; 183(3):321-9. PubMed ID: 10797306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Specificity and heregulin regulation of Ebp1 (ErbB3 binding protein 1) mediated repression of androgen receptor signalling.
    Zhang Y; Hamburger AW
    Br J Cancer; 2005 Jan; 92(1):140-6. PubMed ID: 15583694
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.
    Awasthi S; Hamburger AW
    J Cell Physiol; 2014 Nov; 229(11):1831-41. PubMed ID: 24692179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.
    Awasthi S; Ezelle H; Hassel BA; Hamburger AW
    Mol Cell Biochem; 2015 Jul; 405(1-2):177-86. PubMed ID: 25876877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in heregulin beta1 (HRGbeta1) signaling after inhibition of ErbB-2 expression in a human breast cancer cell line.
    Yoo JY; Hamburger AW
    Mol Cell Endocrinol; 1998 Mar; 138(1-2):163-71. PubMed ID: 9685225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G; Heiss P; Schlegel J; Hofstaedter F; Knuechel R
    Cytometry; 2001 Aug; 44(4):338-48. PubMed ID: 11500850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HRG-β1-driven ErbB3 signaling induces epithelial-mesenchymal transition in breast cancer cells.
    Kim J; Jeong H; Lee Y; Kim C; Kim H; Kim A
    BMC Cancer; 2013 Aug; 13():383. PubMed ID: 23937725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.
    Ghosh A; Awasthi S; Hamburger AW
    Oncol Rep; 2013 Mar; 29(3):1161-6. PubMed ID: 23242156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulvestrant-induced expression of ErbB3 and ErbB4 receptors sensitizes oestrogen receptor-positive breast cancer cells to heregulin β1.
    Hutcheson IR; Goddard L; Barrow D; McClelland RA; Francies HE; Knowlden JM; Nicholson RI; Gee JM
    Breast Cancer Res; 2011 Mar; 13(2):R29. PubMed ID: 21396094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.
    Hamburger AW
    J Mammary Gland Biol Neoplasia; 2008 Jun; 13(2):225-33. PubMed ID: 18425425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Nrdp1 enhances ErbB2/ErbB3-dependent breast tumor cell growth.
    Yen L; Cao Z; Wu X; Ingalla ER; Baron C; Young LJ; Gregg JP; Cardiff RD; Borowsky AD; Sweeney C; Carraway KL
    Cancer Res; 2006 Dec; 66(23):11279-86. PubMed ID: 17145873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.
    Ghosh A; Awasthi S; Peterson JR; Hamburger AW
    Br J Cancer; 2013 Feb; 108(3):557-63. PubMed ID: 23361053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heregulin-beta1 regulates the estrogen receptor-alpha gene expression and activity via the ErbB2/PI 3-K/Akt pathway.
    Stoica GE; Franke TF; Wellstein A; Morgan E; Czubayko F; List HJ; Reiter R; Martin MB; Stoica A
    Oncogene; 2003 Apr; 22(14):2073-87. PubMed ID: 12687010
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.